Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors

Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors

US Patent 10184006 · Granted Jan 22, 2019

Estimated economic value: $1,090,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Squeeze-type electrode connector2025
Double-power-supply switching control system for a welding machine and method2021
Display screen or portion thereof with graphical user interface2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Method for lysing a single cell in a solid tissue2018
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer2017
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2017
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2017
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer2016
Screening for gestational disorders2008
Interface between substrates having microarrays and microtiter plates2006